Weight loss injections primarily include glucagon-like peptide-1 (GLP-1) receptor agonists such as semaglutide (Wegovy) and the dual glucose-dependent insulinotropic polypeptide (GIP)/GLP-1 receptor agonist tirzepatide (Zepbound)
All you need to do is make some tweaks to your lifestyle that will help address the above
Studies published in Current Diabetes Reviews and Endocrinology and Metabolism have found that semaglutide (Ozempic) can ultimately lead to sarcopenia , which is characterized by loss of muscle, strength, and function
Even though tirzepatide was created to treat type 2 diabetes, it is also FDA-approved to be used for weight management.
Check the current Lilly eligibility page for the exact device and coverage situation
Future studies are needed to better understand this association, says Jonathan Zontag , lead study author and a researcher at Hebrew University